Cargando…

Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study

OBJECTIVE: We investigated the role of bevacizumab (BV) in high-grade meningiomas (HGMs) by retrospective analysis. METHODS: We retrospectively analyzed the clinical data of 139 patients with HGMs. The chi-square test was used to compare progression-free survival (PFS) and overall survival (OS) betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Xuexue, Liu, Xiaomin, Wen, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364983/ https://www.ncbi.nlm.nih.gov/pubmed/35968510 http://dx.doi.org/10.2147/NDT.S368740

Ejemplares similares

Bevacizumab for the Treatment of High-Grade Meningiomas: Is There New Evidence? [Letter]
por: da Silva, Vinicius Trindade Gomes, et al.
Publicado: (2022)

Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients
por: Nunes, Fabio P., et al.
Publicado: (2013)

The Role of Pre-Operative MRI for Prediction of High-Grade Intracranial Meningioma: A Retrospective Study
por: Radeesri, Kan, et al.
Publicado: (2023)

Genomic landscape of high-grade meningiomas
por: Bi, Wenya Linda, et al.
Publicado: (2017)

Distinguishing grade I meningioma from higher grade meningiomas without biopsy
por: Varlotto, John, et al.
Publicado: (2015)

Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review
por: Belanger, Katherine, et al.
Publicado: (2022)

Erratum: Genomic landscape of high-grade meningiomas
por: Bi, Wenya Linda, et al.
Publicado: (2017)

The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion
por: Jiang, Jun, et al.
Publicado: (2023)

Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy
por: Hoffmann, Elgin, et al.
Publicado: (2021)

The benefit of bevacizumab therapy in patients with refractory vasogenic edema caused by brain metastasis from lung and colon cancers
por: Bai, Xuexue, et al.
Publicado: (2022)

Malignant Subdural Hematoma Associated with High-Grade Meningioma
por: Teramoto, Shinichiro, et al.
Publicado: (2018)

The Role of Adjuvant Treatment in Patients with High-Grade Meningioma
por: Cho, Minjae, et al.
Publicado: (2017)

Boron Neutron Capture Therapy and Photodynamic Therapy for High-Grade Meningiomas
por: Nakahara, Yukiko, et al.
Publicado: (2020)

Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
por: Detti, Beatrice, et al.
Publicado: (2021)

A molecularly integrated grade for meningioma
por: Driver, Joseph, et al.
Publicado: (2021)

A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma
por: Kumthekar, Priya, et al.
Publicado: (2022)

Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo
por: Takeda, Hiroyuki, et al.
Publicado: (2017)

Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literature
por: Jeck, Jennifer, et al.
Publicado: (2018)

High grade spinal meningiomas: a rare but formidable challenge
por: El-Hajj, Victor Gabriel, et al.
Publicado: (2023)

GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma
por: Negroni, Caterina, et al.
Publicado: (2020)

Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas
por: Brastianos, Priscilla K., et al.
Publicado: (2022)

Are the clinical manifestations of CT scan and location associated with World Health Organization histopathological grades of meningioma?: A retrospective study
por: behzadmehr, Razieh, et al.
Publicado: (2021)

COT-21 EFFECT OF BEVACIZUMAB FOR PEDIATRIC HIGH GRADE GLIOMA
por: Tsukamoto, Yoshihiro, et al.
Publicado: (2019)

Radiographic prediction of meningioma grade by semantic and radiomic features
por: Coroller, Thibaud P., et al.
Publicado: (2017)

Prognostic Implication of Preoperative Behavior Changes in Patients with Primary High-Grade Meningiomas
por: Vranic, Andrej, et al.
Publicado: (2014)

Role of bevacizumab for treatment-refractory meningiomas: A systematic analysis and literature review
por: Franke, Aaron J., et al.
Publicado: (2018)

Everolimus and Bevacizumab in the Management of Recurrent, Progressive Intracranial NF2 Mutated Meningioma
por: Mathew Thomas, Vinay, et al.
Publicado: (2019)

Differential Plasma Metabolites between High- and Low-Grade Meningioma Cases
por: Kurokawa, Gabriel A., et al.
Publicado: (2022)

Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial
por: Cohen, Adam L., et al.
Publicado: (2020)

Linear Accelerator–Based Radiosurgery of Grade I Intracranial Meningiomas
por: Alatriste-Martínez, Sara, et al.
Publicado: (2019)

Diagnostic nomogram model for predicting preoperative pathological grade of meningioma
por: Peng, Shijun, et al.
Publicado: (2021)

Grading Meningioma: A Comparative Study of Thallium-SPECT and FDG-PET
por: Okuchi, Sachi, et al.
Publicado: (2015)

World Health Organization meningioma grade II
por: Parkhi, Rutuja Bhaskar, et al.
Publicado: (2022)

Intraoperative Flow Cytometry for the Evaluation of Meningioma Grade
por: Alexiou, George A., et al.
Publicado: (2023)

Histogram Analysis Parameters Apparent Diffusion Coefficient for Distinguishing High and Low-Grade Meningiomas: A Multicenter Study
por: Surov, Alexey, et al.
Publicado: (2018)

Bevacizumab is associated with cerebral microstructural alterations: a DTI study in high-grade glioma
por: Kassubek, Rebecca, et al.
Publicado: (2023)

Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes
por: Bovi, Joseph A., et al.
Publicado: (2020)

Efficacy of Topical Bevacizumab in High-Risk Corneal Transplant Survival
por: Bhatti, Nasir, et al.
Publicado: (2013)

Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas
por: Tsai, Wen-Chiuan, et al.
Publicado: (2016)

Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial
por: Marchetti, Marcello, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j36iio5rffd7ecs4pelitv8k8p